Status: current, Defined. Date: 31-Jul 2023. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4836431000168114 | Mytolac (lanreotide 60 mg / 0.5 mL) injection, 0.5 mL syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4836441000168117 | Mytolac 60 mg/0.5 mL injection, 0.5 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mytolac 60 mg/0.5 mL injection, 0.5 mL syringe | Is a | Mytolac | true | Inferred relationship | Some | ||
| Mytolac 60 mg/0.5 mL injection, 0.5 mL syringe | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Mytolac 60 mg/0.5 mL injection, 0.5 mL syringe | Is a | lanreotide 60 mg/0.5 mL injection, syringe | true | Inferred relationship | Some | ||
| Mytolac 60 mg/0.5 mL injection, 0.5 mL syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Mytolac 60 mg/0.5 mL injection, 0.5 mL syringe | has unit of use | syringe | true | Inferred relationship | Some | 1540528618 | |
| Mytolac 60 mg/0.5 mL injection, 0.5 mL syringe | has Australian BoSS | lanreotide | true | Inferred relationship | Some | 1835089478 | |
| Mytolac 60 mg/0.5 mL injection, 0.5 mL syringe | has intended active ingredient | lanreotide | true | Inferred relationship | Some | 1835089478 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mytolac 60 mg/0.5 mL injection, 0.5 mL syringe | has TPUU | True | Mytolac 60 mg/0.5 mL injection, 0.5 mL syringe | Inferred relationship | Some | 1063231074 |
| Mytolac 60 mg/0.5 mL injection, 0.5 mL syringe | has TPUU | True | Mytolac 60 mg/0.5 mL injection, 0.5 mL syringe | Inferred relationship | Some | 924947161 |
Reference Sets
Trade product unit of use reference set
FHIR